Systemic to pulmonary arterial shunts are surgically created connections between the aorta and a pulmonary artery in children with cyanotic congenital heart disease, such as tetralogy of Fallot or ...

We previously reported on the partial prevention of experimental shunt-induced pulmonary arterial hypertension (PAH) by the nonselective endothelin (ET) ET-A/ET-B receptor antagonist bosentan. As the ...

Contrast-Enhanced Echocardiogram in a Patient with Hepatopulmonary Syndrome 0m 20s An alternative to echocardiographic studies for the diagnosis of the hepatopulmonary syndrome is the use of ...

Larger DA diameter was significantly related to this low systemic blood flow in the early hours after birth. [13] By the time the PDA became clinically apparent (mean 72 hours), the infants were ...

VENOUS anastomoses connecting the portal and pulmonary veins have been shown in cirrhotic patients by post-mortem injection, 1 and there has been considerable speculation concerning their possible ...

The characteristics of hepatopulmonary syndrome include an oxygen saturation < 80%, an increased alveolar-arterial gradient (> 15 mm Hg) while breathing room air, portal hypertension with or without ...

A pulmonary arteriovenous malformation is an abnormal connection between an artery and a vein within the lungs that allows deoxygenated venous blood to pass directly into the system circulation.

V-Wave has raised $98 million to complete the clinical testing of its implant for severe heart failure and pulmonary arterial hypertension, as well as set up the device for FDA review. The company’s ...